Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss. pdfRead

Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance. pdfread

Bilan semestriel du contrat de liquidité Sensorion avec la société de bourse Kepler Cheuvreux. pdfRead (in french only)

Information relative au nombre total de droits de vote et d’actions composant le capital social. pdfLire

Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models. pdfRead

Pipeline

2018 02 pipeline

Enregistrer

Patient center

Corporate presentation

Next events